Variant ID | 8145 |
---|---|
Entrez Gene ID | 2559 |
Gene | GABRA6 (GeneCards) |
Location | hg19 5:161244756-161244756
hg38 5:161817750-161817750 |
Disease | Asymptomatic |
Method | HiSeq X Ten |
Mutation(HGVS format) | NC_000005.9:g.161244756 T>C (Genome Assembly: GRCh37) |
Exon or Intron | NA |
---|---|
Position in protein | NA |
Amino acid changes in protein | NA > NA |
Position in cDNA | NA |
Changes in cDNA | NA > NA |
mRNA accession | NA |
mRNA length | NA |
Reference length | 180915260 |
MAF in gnomAD genome (version 2.0.1) | 0 |
---|---|
EIGEN score | 0.1881 |
CADD Raw score (version 1.3) | 1.112968 (Deleterious) |
FATHMM raw prediction score | 0.25645 (Tolerated) |
Deleterious probability by DeFine | 0.4653 (Neutral) |
Entrez Gene ID | 2559 (NCBI Gene) |
---|---|
Official Gene Symbol | GABRA6 (GeneCards) |
Number of variants in GABRA6 in this database | 6 (view all the variants) |
Full name | gamma-aminobutyric acid type A receptor alpha6 subunit |
Band | 5q34 |
Other IDs | Vega: OTTHUMG00000130351 OMIM: 137143 HGNC: HGNC:4080 Ensembl: ENSG00000145863 |
Other names | None |
Summary | GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. [provided by RefSeq, Jul 2008] |
Individual ID | 29217584.11 (view all the variants in this individual) |
---|---|
Pubmed ID | 29217584 |
Whose mosaic mutation | Normal |
Phenotype | 1 |
Disease | Asymptomatic |
OMIM ID |
Pubmed ID | 29217584 |
---|---|
Title | Aging and neurodegeneration are associated with increased mutations in single human neurons. |
Journal | Science |
Publication date | 2018.02 |
Disease | Cockayne syndrome Xeroderma Pigmentosum |
Number of cases | Male cases: 3; Female cases: 6; cases of unknown sex: 15; |